Health
India Eyes Biosimilar Insulin Scale-Up Amid Global Supply Concerns
India is stepping up efforts to expand domestic insulin manufacturing and diabetes-related bio-manufacturing, as global supply risks and affordability concerns push policymakers to re-evaluate dependence on a handful of multinational…